Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease

Respiratory Medicine

Volumn 99, Issue 10, 2005, Pages 1229-1240

  Gessner, Christian ^a   Scheibe, Robert ^a   Wötzel, Michael ^a   Hammerschmidt, Stefan ^a   Kuhn, Hartmut ^a   Engelmann, Lothar ^a   Hoheisel, Gerhard ^a   Gillissen, Adrian ^b   Sack, Ulrich ^a   Wirtz, Hubert ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Robert Koch Klinik   (Germany)

Author keywords

Chronic obstructive pulmonary disease; Cytokines; Exhaled breath condensate; Flow cytometry

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BREATH ANALYSIS; BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EXHALATION; EXHALED BREATH CONDENSATE; FEMALE; HUMAN; INFLAMMATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; AMYLASES; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 24344493434     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.02.041     Document Type: Article

References (40)

1. R.A. Pauwels A.S. Buist P.M. Calverley C.R. Jenkins S.S. Hurd Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 5 2001 1256-1276
2. I.S. Patel N.J. Roberts S.J. Lloyd-Owen R.J. Sapsford J.A. Wedzicha Airway epithelial inflammatory responses and clinical parameters in COPD Eur Respir J 22 1 2003 94-99
3. M.J. Gizycki K.L. Hattotuwa N. Barnes P.K. Jeffery Effects of fluticasone propionate on inflammatory cells in COPD: An ultrastructural examination of endobronchial biopsy tissue Thorax 57 9 2002 799-803
4. S.V. Culpitt D.F. Rogers P. Shah et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 1 2003 24-31
5. A. Pesci B. Balbi M. Majori et al. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease Eur Respir J 12 2 1998 380-386
6. W.G. Kuschner A. D'Alessandro H. Wong P.D. Blanc Dose-dependent cigarette smoking-related inflammatory responses in healthy adults Eur Respir J 9 10 1996 1989-1994
7. D. Morrison R.M. Strieter S.C. Donnelly M.D. Burdick S.L. Kunkel W. MacNee Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers Eur Respir J 12 5 1998 1067-1072
8. S. Lim N. Roche B.G. Oliver W. Mattos P.J. Barnes K. Fan Chung Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10 Am J Respir Crit Care Med 162 4 Pt 1 2000 1355-1360
9. V.M. Keatings P.D. Collins D.M. Scott P.J. Barnes Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma Am J Respir Crit Care Med 153 2 1996 530-534
10. A.T. Hill D. Bayley R.A. Stockley The interrelationship of sputum inflammatory markers in patients with chronic bronchitis Am J Respir Crit Care Med 160 3 1999 893-898
11. C. Yamamoto T. Yoneda M. Yoshikawa et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8 Chest 112 2 1997 505-510
12. K.M. Beeh J. Beier O. Kornmann A. Mander R. Buhl Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD Chest 123 3 2003 778-783
13. J.H. Vernooy M. Kucukaycan J.A. Jacobs et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum Am J Respir Crit Care Med 166 9 2002 1218-1224
14. P. Montuschi J.V. Collins G. Ciabattoni et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers Am J Respir Crit Care Med 162 3 Pt 1 2000 1175-1177
15. S.A. Kharitonov P.J. Barnes Exhaled markers of inflammation Curr Opin Allergy Clin Immunol 1 3 2001 217-224
16. E. Bucchioni S.A. Kharitonov L. Allegra P.J. Barnes High levels of interleukin-6 in the exhaled breath condensate of patients with COPD Respir Med 97 12 2003 1299-1302
17. K.W. Garey M.M. Neuhauser R.A. Robbins L.H. Danziger I. Rubinstein Markers of inflammation in exhaled breath condensate of young healthy smokers Chest 125 1 2004 22-26
18. C. Gessner S. Hammerschmidt H. Kuhn et al. Exhaled breath condensate acidification in acute lung injury Respir Med 97 11 2003 1188-1194
19. A. Bhowmik T.A. Seemungal R.J. Sapsford J.A. Wedzicha Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Thorax 55 2 2000 114-120
20. J.A. Wedzicha T.A. Seemungal P.K. MacCallum et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels Thromb Haemost 84 2 2000 210-215
21. P. Bresser T.A. Out L. van Alphen H.M. Jansen R. Lutter Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 162 3 Pt 1 2000 947-952
22. S.D. Aaron J.B. Angel M. Lunau et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 2 2001 349-355
23. S. Burge J.A. Wedzicha COPD exacerbations: Definitions and classifications Eur Respir J 41 Suppl 2003 46s-53s
24. M.B. Amato C.S. Barbas D.M. Medeiros et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome N Engl J Med 338 6 1998 347-354
25. N.R. Anthonisen J. Manfreda C.P. Warren E.S. Hershfield G.K. Harding N.A. Nelson Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 2 1987 196-204
26. C. Gessner H. Kuhn H.J. Seyfarth et al. Factors influencing breath condensate volume Pneumologie 55 9 2001 414-419
27. G.W. Hunninghake J.E. Gadek O. Kawanami V.J. Ferrans R.G. Crystal Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage Am J Pathol 97 1 1979 149-206
28. E. Huszar G. Vass E. Vizi et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma Eur Respir J 20 6 2002 1393-1398
29. R.M. Effros K.W. Hoagland M. Bosbous et al. Dilution of respiratory solutes in exhaled condensates Am J Respir Crit Care Med 165 5 2002 663-669
30. K.M. Beeh O. Kornmann R. Buhl S.V. Culpitt M.A. Giembycz P.J. Barnes Neutrophil chemotactic activity of sputum from patients with COPD: Role of interleukin 8 and leukotriene B4 Chest 123 4 2003 1240-1247
31. M. Nys G. Deby-Dupont Y. Habraken et al. Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: Role of reactive oxygen/nitrogen species and cytokines Nitric Oxide 9 1 2003 33-43
32. T.A. Seemungal R. Harper-Owen A. Bhowmik D.J. Jeffries J.A. Wedzicha Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease Eur Respir J 16 4 2000 677-683
33. N. Soler S. Ewig A. Torres X. Filella J. Gonzalez A. Zaubet Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease Eur Respir J 14 5 1999 1015-1022
34. G.E. Carpagnano S.A. Kharitonov M.P. Foschino-Barbaro O. Resta E. Gramiccioni P.J. Barnes Increased inflammatory markers in the exhaled breath condensate of cigarette smokers Eur Respir J 21 4 2003 589-593
35. S.V. Culpitt W. Maziak S. Loukidis J.A. Nightingale J.L. Matthews P.J. Barnes Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 5 Pt 1 1999 1635-1639
36. K. Ito S. Lim G. Caramori K.F. Chung P.J. Barnes I.M. Adcock Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages Faseb J 15 6 2001 1110-1112
37. P.J. Barnes K. Ito I.M. Adcock Corticosteroid resistance in chronic obstructive pulmonary disease: Inactivation of histone deacetylase Lancet 363 9410 2004 731-733
38. P. van der Valk E. Monninkhof J. van der Palen G. Zielhuis C. van Herwaarden Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: The COPE study Am J Respir Crit Care Med 166 10 2002 1358-1363
39. S. Gompertz D.L. Bayley S.L. Hill R.A. Stockley Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD Thorax 56 1 2001 36-41
40. C. Gessner S. Hammerschmidt H. Kuhn et al. Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury Chest 124 3 2003 1046-1052